FENNEC PHARMACEUTICALS INC. - Common Shares (FENC)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class: Equity / Common Shares
Shares outstanding: 27.7M
Number of holders: 10
Total 13F shares, excl. options: 5.21M
Shares change: +5.21M
Total reported value, excl. options: $57.7M
Value change: +$57.7M
Number of buys: 10
Price: $11.03

Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q3 2017

10 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q3 2017.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.21M shares of 27.7M outstanding shares and own 18.83% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), 683 Capital Management, LLC (808K shares), ACUTA CAPITAL PARTNERS, LLC (250K shares), venBio Select Advisor LLC (66.7K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (49.6K shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (41.1K shares), Hartford Financial Management Inc. (1.15K shares), Tower Research Capital LLC (TRC) (400 shares), UBS Group AG (79 shares), and Federation des caisses Desjardins du Quebec (4 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.